 |
인쇄하기
취소
|
Jeil Pharm, Takeda Korea sign distribution agreement for Dexilant
Jeil Pharmaceutical Wednesday signed a distribution agreement with Takeda Korea to sell Takeda’s new proton-pump inhibitor Dexilant (dexlansoprazole) in Korea.
The launching ceremony was held at the Park Hyatt Hotel in Seoul, where Haruhiko Hirate of Takeda’s North Asia chief, President Lee Choon-yeob of Takeda Korea, Chairman Han Seung-soo of Jeil Pharm and president Sung Seok-jae of Jeil P...
The launching ceremony was held at the Park Hyatt Hotel in Seoul, where Haruhiko Hirate of Takeda’s North Asia chief, President Lee Choon-yeob of Takeda Korea, Chairman Han Seung-soo of Jeil Pharm and president Sung Seok-jae of Jeil P...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.